Public Company News

iQIYI's 'Love On Theater' Premieres 'Fangs of Fortune,' Setting Benchmark for C-Drama Virtual Production

BEIJING, Oct. 31, 2024 /PRNewswire/ -- iQIYI, China's leading online entertainment platform, premieredFangs of Fortune in late October, the latest release under 'Love On Theater.' Inspired byThe Classic of the Mountains and Seas, an ancient Chinese mythological text, this fantasy period drama unf...

2024-10-31 20:15 4196

Ping An Health Achieves WONCA International Quality Dual Certifications Defining New Standards in Internet Healthcare Services

HONG KONG and SHANGHAI, Oct. 31, 2024 /PRNewswire/ -- Ping An Healthcare and Technology Company Limited ("Ping An Good Doctor", "Ping An Health", or "the Company", Stock Code: 1833.HK) received the Digital Health Certification (DHC) and the Continuous Professional Development (CPD) certifications...

2024-10-31 20:14 2898

Far Eastern New Century Empowering Possibilities & Sustainability by its Latest Recycling Technologies at TITAS

TAIPEI, Oct. 31, 2024 /PRNewswire/ -- Far Eastern New Century Corporation (FENC), a global leader in advancing sustainability and innovation in green materials, showcased its latest recycling technologies and product solutions under the theme "Empowering Possibilities & Sustainability" at the Tai...

2024-10-31 20:00 5826

NaaS Technology CFO to Headline UBS Charging Industry Call Series

BEIJING, Oct. 31, 2024 /PRNewswire/ -- NaaS Technology Inc. (Nasdaq: NAAS) ("NaaS" or the "Company"), the first U.S.-listed EV charging service company in China, today announced that Mr. Steven Sim, Chief Financial Officer of NaaS, will be featured on UBS's Charging Industry Call Series onNovember...

2024-10-31 20:00 2773

Cango Inc. to Report Third Quarter 2024 Financial Results on November 4, 2024 Eastern Time

SHANGHAI, Oct. 31, 2024 /PRNewswire/ -- Cango Inc. (NYSE: CANG) ("Cango" or the "Company"), a leading automotive transaction service platform in China, today announced that it plans to release its third quarter 2024 financial results after the market closes on Monday, November 4, 2024. The earnin...

2024-10-31 20:00 3629

Medera Announces Publication of Study Utilizing Machine Learning to Enhance Next-Generation Drug Screening with Human mini-Heart Technology

* Traditional methods for evaluating therapeutic efficacy and cardiotoxicity often lead to high failure rates during clinical trials, resulting in significant development costs * Human-specific diseases cannot be accurately modeled by animals, leading to limited medical options or advancemen...

2024-10-31 20:00 2367

I-Mab to Release Q3 2024 Financial Results on November 14, 2024

ROCKVILLE, Md., Oct. 31, 2024 /PRNewswire/ -- I-Mab (NASDAQ: IMAB) (the "Company"), a US-based, global biotech company, exclusively focused on the development of highly differentiated immunotherapies for the treatment of cancer, today announced that it plans to release financial results for the ...

2024-10-31 19:00 3694

Recurrent Energy to deliver 1,800 MWh of energy storage and 150 MWac of solar capacity to Arizona Public Service by 2026

Recurrent Energy's latest energy storage and solar tolling agreements with APS supportArizona's expanding energy needs GUELPH, ON and PHOENIX, Oct. 31, 2024 /PRNewswire/ -- Recurrent Energy , a subsidiary of Canadian Solar Inc. ("Canadian Solar") (NASDAQ: CSIQ) and ...

2024-10-31 19:00 2694

Recurrent Energy Announces Successful Operation of 134 MW Solar Project

Autodesk, Inc., Biogen Inc., EMD Electronics and Wayfair Inc. are now purchasing renewable energy from theTexas project HOUSTON and GUELPH, ON, Oct. 31, 2024 /PRNewswire/ -- Recurrent Energy , a subsidiary of Canadian Solar Inc . ("Can...

2024-10-31 19:00 3795

China Yuchai Terminates Its Share Buyback Plan

SINGAPORE, Oct. 31, 2024 /PRNewswire/ -- China Yuchai International Limited (NYSE: CYD)("China Yuchai" or the "Company") today announced that its Board of Directors has approved to terminate its share buyback plan with immediate effect.  The share buyback plan was adopted on June 7, 2024, under ...

2024-10-31 18:00 4171

Hyundai Motor Unveils Next Step in its Hydrogen Legacy with new INITIUM FCEV Concept

* Hyundai Motor Company holds 'Clearly Committed' event in Korea to reinforce its vision for a hydrogen future * INITIUM hydrogen fuel cell concept vehicle showcases the company's new 'Art of Steel' design language and reflects Hyundai Motor's customer-centric approach * Hyundai Motor Group E...

2024-10-31 17:35 4251

Achieved IDR 45.36 Trillion Profit in Q3 2024, BRI Strengthens Performance Fundamentals

JAKARTA, Indonesia, Oct. 31, 2024 /PRNewswire/ -- PT. Bank Rakyat Indonesia (Persero) Tbk (IDX: BBRI) maintained its strong performance amidst global and domestic economic challenges, achieving a net profit ofIDR 45.36 trillion in the third quarter of 2014. At the financial performance press conf...

2024-10-31 17:32 6920

Ericsson targets high-performing programmable networks with new 5G Advanced software

* High-performing programmable networks empower communications service providers (CSPs) to steer network behavior, aligning it with diverse business goals for optimal outcomes * Seven new 5G Advanced software products for high-performing programmable networks will substantially increase reven...

2024-10-31 17:22 3382

NetEase to Report Third Quarter 2024 Financial Results on November 14

HANGZHOU, China, Oct. 31, 2024 /PRNewswire/ -- NetEase, Inc. (NASDAQ: NTES and HKEX: 9999, "NetEase" or the "Company"), a leading internet and game services provider, today announced that it will report financial results for the 2024 third quarter onThursday, November 14, 2024, before the open of...

2024-10-31 16:30 3222

Youdao to Report Third Quarter 2024 Financial Results on November 14

HANGZHOU, China, Oct. 31, 2024 /PRNewswire/ -- Youdao, Inc. ("Youdao" or the "Company") (NYSE: DAO), an intelligent learning company with industry-leading technology inChina, today announced that it will report its third quarter 2024 financial results onThursday, November 14, 2024, before the ope...

2024-10-31 16:30 2514

Full Truck Alliance Co. Ltd. to Announce Third Quarter 2024 Financial Results on Wednesday, November 20, 2024

Earnings Call Scheduled for 7:00 A.M. U.S. ET on November 20, 2024  GUIYANG, China, Oct. 31, 2024 /PRNewswire/ -- Full Truck Alliance Co. Ltd. ("FTA" or the "Company") (NYSE: YMM), a leading digital freight platform, today announced that it will release its third quarter 2024 unaudited financial ...

2024-10-31 16:00 2919

"Bleach: Brave Souls" Anime Broadcast Celebration Special: Thousand-Year Blood War Zenith Summons: Puppets Begins with Thousand-Year Blood War 2024 Versions of Giselle & Others

TOKYO, Oct. 31, 2024 /PRNewswire/ -- KLab Inc., a leader in online mobile games, announced that its hit 3D action gameBleach: Brave Souls will be holding the Anime Broadcast Celebration Special: Thousand-Year Blood War Zenith Summons: Puppets to celebrate the broadcasting of the animated TV serie...

2024-10-31 15:40 4246

ZYMFENTRA® (infliximab-dyyb) coverage continues to increase through partnership with top 3 Pharmacy Benefit Managers (PBMs)

* Celltrion USA has expanded access to ZYMFENTRA® (infliximab-dyyb), the first and only FDA-approved subcutaneous (SC) infliximab, to a significant share of the U.S. market * The availability of ZYMFENTRA will support greater patient access and choice while helping to drive greater affordabil...

2024-10-31 14:31 2485

CStone Announces MHRA Approval of Sugemalimab for First-Line Treatment of Non-Small Cell Lung Cancer (NSCLC) in the UK

* This approval marks the second international marketing authorization for sugemalimab outside ofChina, following its recent approval by the European Commission. * The approval is based on results from the Phase 3 GEMSTONE-302 clinical trial, which demonstrated that sugemalimab in combination...

2024-10-31 13:00 4492

Kelun-Biotech's TROP2-ADC SKB264 (sac-TMT) Third NDA Accepted by NMPA, locally advanced or metastatic EGFR-mutant NSCLC

CHENGDU, China, Oct. 31, 2024 /PRNewswire/ -- The new drug application (NDA) (the "Application") based on the positive results from the pivotal phase III OptiTROP-Lung04 study of sacituzumab tirumotecan (sac-TMT, formerly SKB264/MK-2870) developed by Sichuan Kelun-Biotech Biopharmaceutical Co., L...

2024-10-31 12:34 3000